Search results
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
Zacks via Yahoo Finance· 2 days agoThe biotechnology industry had a rough first quarter after a decent performance in 2023. The...
Is Vir Biotechnology (NASDAQ:VIR) In A Good Position To Deliver On Growth Plans?
Simply Wall St. via Yahoo Finance· 5 days agoNonetheless, only a fool would ignore the risk that a loss making company burns through its cash too...
Puma biotechnology executive sells $89.8k in stock By Investing.com
Investing.com· 5 days agoAdrian Senderowicz, a director at Puma Biotechnology, Inc. (NASDAQ:PBYI), has sold a total of 27,000...
Puma Biotechnology director sells shares worth over $33k By Investing.com
Investing.com· 5 days agoPuma Biotechnology, Inc. (NASDAQ:PBYI) has witnessed a recent stock transaction involving one of its...
Objective Capital Management LLC Grows Stock Position in iSharesBiotechnology ETF (NASDAQ:IBB)
ETF DAILY NEWS· 6 days agoObjective Capital Management LLC lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 30.1% during the fourth quarter, according to its most recent ...
Newbridge Financial Services Group Inc. Reduces Stock Position in iShares Biotechnology ETF...
ETF DAILY NEWS· 4 days agoNewbridge Financial Services Group Inc. lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 19.8% during the fourth quarter, according ...
Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning...
Morningstar· 3 days ago"We're pleased to launch this new collaboration with an institution that precisely aligns to our company priorities to invest in the growth and delivery of innovative health solutions and strong ...
Genetic Technologies to Host Investor Webinar By Investing.com
Investing.com· 1 day agoGenetic Technologies Ltd (NASDAQ:GENE), a biotechnology company specializing in genetic testing,...
Guggenheim Initiates Coverage on Repligen (NASDAQ:RGEN)
ETF DAILY NEWS· 4 days agoThe firm issued a neutral rating on the biotechnology company’s stock. JPMorgan Chase & Co. dropped their target price on shares of Repligen from $230.00 to $200.00 and set ...
Insider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
GuruFocus.com via Yahoo Finance· 23 hours agoOn June 18, 2024, James Young, Director at Novavax Inc (NASDAQ:NVAX), executed a sale of 7,500...